Prevalence of childhood obesity in Brazil: systematic review and meta-analysis

Carolina Muller Ferreira1, Natália Dutra Dos Reis1, Andresa de Oliveira Castro1

  • 1Universidade Estadual de Campinas, Faculdade de Ciências Farmacêuticas, Campinas, SP, Brazil.

Jornal De Pediatria
|February 12, 2021
PubMed

Insights

Childhood obesity prevalence in Brazil was 8.2% over three decades, rising to 12% in recent estimates. Boys and children in more developed regions showed higher rates, with significant increases over time.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood obesity is a growing global concern with significant health implications.
  • Brazil faces a substantial burden of childhood obesity, necessitating accurate prevalence data.

Purpose of the Study:

  • To systematically review and estimate the prevalence of childhood obesity in Brazil using representative population-based studies.
  • To analyze trends and variations in childhood obesity prevalence across different decades and Brazilian regions.

Main Methods:

  • A systematic search of multiple databases (MEDLINE, EMBASE, Scopus) was conducted up to September 2019.
  • Fifty-three population-based studies (n=122,395) assessing obesity in children under 10 years were included.
  • Meta-analysis with Freeman-Tukey transformation was used to calculate prevalence (95% CI), and meta-regression/Egger's test assessed heterogeneity and publication bias.

Main Results:

  • The overall prevalence of childhood obesity in Brazil was 8.2% (95% CI: 8.1-8.4%) across the three decades studied (1986-2015).
  • Prevalence increased significantly over time, from 6.5% in the 1990s to 12.0% in the 2010s.
  • Higher prevalence was observed in boys (9.7%) compared to girls (7.3%), and varied by region, with the Southeast (10.6%) and South (10.1%) showing higher rates.

Conclusions:

  • Childhood obesity affects over 8% of Brazilian children on average, with recent estimates reaching 12%.
  • Prevalence is higher in boys, recent decades, and more developed regions, indicating a concerning upward trend.
  • These findings highlight the need for targeted public health interventions to address childhood obesity in Brazil.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
919
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
969
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
101
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
75
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
287